ROTHBLATT MARTINE A
SEC CIK 1106578 · EDGAR
BoughtSold
Most active insiders at UTHR, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | ROTHBLATT MARTINE A | COB, CEO, Dir | -$863.9K | $841.11M |
| 2 | BENKOWITZ MICHAEL | Pres AND COO | — | $226.97M |
| 3 | EDGEMOND JAMES | CFO AND Treas | — | $211.57M |
| 4 | MAHON PAUL A | EVP, GC | — | $114.08M |
| 5 | SULLIVAN LOUIS W | Dir | — | $3.05M |
| 6 | PATUSKY CHRISTOPHER | Dir | — | $2.73M |
| 7 | Thompson Tommy G | Dir | — | $2.51M |
| 8 | KURZWEIL RAY | Dir | — | $2.40M |
| 9 | CAUSEY CHRISTOPHER | Dir | — | $2.33M |
| 10 | Olian Judy D. | Dir | — | $417.0K |
Transactions 665
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2024-07-23 | 2024-07-19+ | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | S - Sale+OE | $330.45 | -7,200 | 130 | -98% | -$2.38M |
| DM | 2024-07-19 | 2024-07-17+ | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | S - Sale+OE | $332.74 | -7,200 | 3,508 | -67% | -$2.40M |
| DM | 2024-07-19 | 2024-07-17+ | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | M - OptEx | $129.49 | +7,200 | 3,730 | New | +$932.3K |
| DM | 2024-07-17 | 2024-07-15+ | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | S - Sale+OE | $327.16 | -7,200 | 163 | -98% | -$2.36M |
| DM | 2024-07-17 | 2024-07-15+ | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | M - OptEx | $129.49 | +7,200 | 3,730 | New | +$932.3K |
| DM | 2024-07-15 | 2024-07-11+ | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | M - OptEx | $129.49 | +7,200 | 3,730 | New | +$932.3K |
| DM | 2024-07-15 | 2024-07-11+ | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | S - Sale+OE | $325.47 | -7,200 | 130 | -98% | -$2.34M |
| DM | 2024-07-11 | 2024-07-09+ | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | M - OptEx | $129.49 | +7,200 | 3,730 | New | +$932.3K |
| DM | 2024-07-11 | 2024-07-09+ | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | S - Sale+OE | $324.54 | -7,200 | 3,528 | -67% | -$2.34M |
| DM | 2024-07-09 | 2024-07-05+ | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | S - Sale+OE | $315.15 | -7,200 | 929 | -89% | -$2.27M |
| DM | 2024-07-09 | 2024-07-05+ | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | M - OptEx | $129.49 | +7,200 | 3,730 | New | +$932.3K |
| DM | 2024-07-05 | 2024-07-02+ | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | M - OptEx | $129.49 | +7,200 | 3,730 | New | +$932.3K |
| DM | 2024-07-05 | 2024-07-02+ | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | S - Sale+OE | $315.35 | -7,200 | 130 | -98% | -$2.27M |
| DM | 2024-07-02 | 2024-06-28+ | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | S - Sale+OE | $319.51 | -7,200 | 1,500 | -83% | -$2.30M |
| DM | 2024-07-02 | 2024-06-28+ | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | M - OptEx | $129.49 | +7,200 | 3,730 | New | +$932.3K |
| DM | 2024-06-28 | 2024-06-26+ | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | M - OptEx | $129.49 | +7,200 | 3,730 | New | +$932.3K |
| DM | 2024-06-28 | 2024-06-26+ | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | S - Sale+OE | $317.49 | -7,200 | 130 | -98% | -$2.29M |
| DM | 2024-06-26 | 2024-06-24+ | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | S - Sale+OE | $317.65 | -7,200 | 3,634 | -66% | -$2.29M |
| DM | 2024-06-26 | 2024-06-24+ | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | M - OptEx | $129.49 | +7,200 | 3,730 | New | +$932.3K |
| DM | 2024-06-24 | 2024-06-20+ | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | S - Sale+OE | $311.44 | -7,200 | 2,365 | -75% | -$2.24M |
| DM | 2024-06-24 | 2024-06-20+ | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | M - OptEx | $129.49 | +7,200 | 3,730 | New | +$932.3K |
| DM | 2024-06-20 | 2024-06-17+ | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | S - Sale+OE | $298.57 | -7,200 | 3,418 | -68% | -$2.15M |
| DM | 2024-06-20 | 2024-06-17+ | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | M - OptEx | $129.49 | +7,200 | 3,730 | New | +$932.3K |
| DM | 2024-06-17 | 2024-06-14 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | S - Sale+OE | $287.22 | -3,600 | 2,457 | -59% | -$1.03M |
| D | 2024-06-17 | 2024-06-14 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | M - OptEx | $129.49 | +3,600 | 3,730 | +2,769% | +$466.2K |
| DM | 2024-06-14 | 2024-06-13 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | S - Sale+OE | $285.47 | -3,600 | 1,248 | -74% | -$1.03M |
| D | 2024-06-14 | 2024-06-13 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | M - OptEx | $129.49 | +3,600 | 3,730 | +2,769% | +$466.2K |
| DM | 2024-06-13 | 2024-06-11+ | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | S - Sale+OE | $278.45 | -7,200 | 1,929 | -79% | -$2.00M |
| DM | 2024-06-13 | 2024-06-11+ | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | M - OptEx | $129.49 | +7,200 | 3,730 | New | +$932.3K |
| DM | 2024-06-11 | 2024-06-07+ | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | S - Sale+OE | $275.54 | -7,200 | 130 | -98% | -$1.98M |
| DM | 2024-06-11 | 2024-06-07+ | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | M - OptEx | $129.49 | +7,200 | 3,730 | New | +$932.3K |
| DM | 2024-06-07 | 2024-06-05+ | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | M - OptEx | $129.49 | +7,200 | 3,730 | New | +$932.3K |
| DM | 2024-06-07 | 2024-06-05+ | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | S - Sale+OE | $277.24 | -7,200 | 130 | -98% | -$2.00M |
| DM | 2024-06-05 | 2024-06-03+ | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | S - Sale+OE | $275.01 | -7,200 | 130 | -98% | -$1.98M |
| DM | 2024-06-05 | 2024-06-03+ | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | M - OptEx | $129.49 | +7,200 | 3,730 | New | +$932.3K |
| DM | 2024-06-03 | 2024-05-30+ | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | S - Sale+OE | $271.29 | -7,200 | 2,627 | -73% | -$1.95M |
| DM | 2024-06-03 | 2024-05-30+ | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | M - OptEx | $129.49 | +7,200 | 3,730 | New | +$932.3K |
| DM | 2024-05-30 | 2024-05-28+ | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | Dir | S - Sale+OE | $268.09 | -7,200 | 3,434 | -68% | -$1.93M |
| DM | 2024-05-30 | 2024-05-28+ | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | Dir | M - OptEx | $129.49 | +7,200 | 3,730 | New | +$932.3K |
| DM | 2024-05-28 | 2024-05-23+ | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | Dir | S - Sale+OE | $274.16 | -7,200 | 1,738 | -81% | -$1.97M |
| DM | 2024-05-28 | 2024-05-23+ | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | Dir | M - OptEx | $129.49 | +7,200 | 3,730 | New | +$932.3K |
| DM | 2024-05-23 | 2024-05-22 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | Dir | S - Sale+OE | $277.20 | -3,600 | 3,008 | -54% | -$997.9K |
| D | 2024-05-23 | 2024-05-22 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | Dir | M - OptEx | $129.49 | +3,600 | 3,730 | +2,769% | +$466.2K |
| DM | 2024-05-22 | 2024-05-20+ | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | Dir | M - OptEx | $129.49 | +7,200 | 3,730 | New | +$932.3K |
| DM | 2024-05-22 | 2024-05-20+ | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | Dir | S - Sale+OE | $274.97 | -7,200 | 2,828 | -72% | -$1.98M |
| DM | 2024-05-20 | 2024-05-16+ | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | Dir | M - OptEx | $129.49 | +7,200 | 3,730 | New | +$932.3K |
| DM | 2024-05-20 | 2024-05-16+ | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | Dir | S - Sale+OE | $272.82 | -7,200 | 663 | -92% | -$1.96M |
| DM | 2024-05-16 | 2024-05-14+ | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | S - Sale+OE | $270.35 | -7,200 | 130 | -98% | -$1.95M |
| DM | 2024-05-16 | 2024-05-14+ | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | M - OptEx | $129.49 | +7,200 | 3,730 | New | +$932.3K |
| DM | 2024-05-14 | 2024-05-10+ | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | S - Sale+OE | $265.49 | -7,200 | 130 | -98% | -$1.91M |
| DM | 2024-05-14 | 2024-05-10+ | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | M - OptEx | $129.49 | +7,200 | 3,730 | New | +$932.3K |
| DM | 2024-05-10 | 2024-05-08+ | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | M - OptEx | $129.49 | +7,200 | 3,730 | New | +$932.3K |
| DM | 2024-05-10 | 2024-05-08+ | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | S - Sale+OE | $263.67 | -7,200 | 130 | -98% | -$1.90M |
| DM | 2024-05-08 | 2024-05-07 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | S - Sale+OE | $263.82 | -3,600 | 130 | -97% | -$949.7K |
| D | 2024-05-08 | 2024-05-07 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | M - OptEx | $129.49 | +3,600 | 3,730 | +2,769% | +$466.2K |
| DM | 2024-05-07 | 2024-05-03+ | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | S - Sale+OE | $259.90 | -7,200 | 276 | -96% | -$1.87M |
| DM | 2024-05-07 | 2024-05-03+ | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | M - OptEx | $129.49 | +7,200 | 3,730 | New | +$932.3K |
| DM | 2024-05-03 | 2024-05-01+ | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | S - Sale+OE | $254.15 | -7,200 | 403 | -95% | -$1.83M |
| DM | 2024-05-03 | 2024-05-01+ | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | M - OptEx | $129.49 | +7,200 | 3,730 | New | +$932.3K |
| DM | 2024-05-01 | 2024-04-29+ | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | S - Sale+OE | $237.00 | -7,200 | 130 | -98% | -$1.71M |
| DM | 2024-05-01 | 2024-04-29+ | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | M - OptEx | $129.49 | +7,200 | 3,730 | New | +$932.3K |
| DM | 2024-04-29 | 2024-04-25+ | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | M - OptEx | $129.49 | +7,200 | 3,730 | New | +$932.3K |
| DM | 2024-04-29 | 2024-04-25+ | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | S - Sale+OE | $235.36 | -7,200 | 130 | -98% | -$1.69M |
| DM | 2024-04-25 | 2024-04-23+ | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | S - Sale+OE | $237.60 | -7,200 | 3,194 | -69% | -$1.71M |
| DM | 2024-04-25 | 2024-04-23+ | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | M - OptEx | $129.49 | +7,200 | 3,730 | New | +$932.3K |
| DM | 2024-04-23 | 2024-04-19+ | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | M - OptEx | $129.49 | +7,200 | 3,730 | New | +$932.3K |
| DM | 2024-04-23 | 2024-04-19+ | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | S - Sale+OE | $236.69 | -7,200 | 130 | -98% | -$1.70M |
| DM | 2024-04-19 | 2024-04-17+ | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | S - Sale+OE | $236.81 | -7,200 | 3,596 | -67% | -$1.71M |
| DM | 2024-04-19 | 2024-04-17+ | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | M - OptEx | $129.49 | +7,200 | 3,730 | New | +$932.3K |
| DM | 2024-04-17 | 2024-04-15+ | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | M - OptEx | $129.49 | +7,200 | 3,730 | New | +$932.3K |
| DM | 2024-04-17 | 2024-04-15+ | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | S - Sale+OE | $233.72 | -7,200 | 385 | -95% | -$1.68M |
| DM | 2024-04-15 | 2024-04-11+ | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | S - Sale+OE | $237.19 | -7,200 | 347 | -95% | -$1.71M |
| DM | 2024-04-15 | 2024-04-11+ | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | M - OptEx | $129.49 | +7,200 | 3,730 | New | +$932.3K |
| DM | 2024-04-11 | 2024-04-09+ | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | S - Sale+OE | $237.21 | -28.8K | 130 | -100% | -$6.83M |
| DM | 2024-04-11 | 2024-04-09+ | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | M - OptEx | $129.49 | +28.8K | 15.1K | New | +$3.73M |
| DM | 2024-04-09 | 2024-04-05+ | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | S - Sale+OE | $235.68 | -20.1K | 14.9K | -57% | -$4.73M |
| DM | 2024-04-09 | 2024-04-05+ | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | M - OptEx | $129.49 | +20.1K | 15.1K | New | +$2.60M |
| DM | 2024-04-05 | 2024-04-03+ | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | S - Sale+OE | $231.92 | -30.0K | 796 | -97% | -$6.96M |
| DM | 2024-04-05 | 2024-04-03+ | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | M - OptEx | $129.49 | +30.0K | 15.1K | New | +$3.88M |
| DM | 2024-04-03 | 2024-04-01+ | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | S - Sale+OE | $228.69 | -30.0K | 130 | -100% | -$6.86M |
| DM | 2024-04-03 | 2024-04-01+ | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | M - OptEx | $129.49 | +30.0K | 15.1K | New | +$3.88M |
| DM | 2024-03-29 | 2024-03-27+ | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | S - Sale+OE | $239.05 | -29.1K | 2,885 | -91% | -$6.96M |
| DM | 2024-03-29 | 2024-03-27+ | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | M - OptEx | $129.49 | +29.1K | 14.3K | New | +$3.77M |
| DM | 2024-03-27 | 2024-03-25+ | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | S - Sale+OE | $245.84 | -30.0K | 14.5K | -67% | -$7.38M |
| DM | 2024-03-27 | 2024-03-25+ | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | M - OptEx | $129.49 | +30.0K | 15.1K | New | +$3.88M |
| DM | 2024-03-25 | 2024-03-21+ | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | S - Sale+OE | $236.70 | -30.0K | 3,791 | -89% | -$7.10M |
| DM | 2024-03-25 | 2024-03-21+ | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | M - OptEx | $129.49 | +30.0K | 15.1K | New | +$3.88M |
| DM | 2024-03-21 | 2024-03-19+ | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | S - Sale+OE | $236.27 | -30.0K | 7,561 | -80% | -$7.09M |
| DM | 2024-03-21 | 2024-03-19+ | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | M - OptEx | $129.49 | +30.0K | 15.1K | New | +$3.88M |
| DM | 2024-03-19 | 2024-03-15+ | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | S - Sale+OE | $235.54 | -30.0K | 12.5K | -71% | -$7.07M |
| DM | 2024-03-19 | 2024-03-15+ | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | M - OptEx | $129.49 | +30.0K | 15.1K | New | +$3.88M |
| DM | 2024-03-15 | 2024-03-13+ | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | M - OptEx | $129.49 | +30.0K | 15.1K | New | +$3.88M |
| DM | 2024-03-15 | 2024-03-13+ | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | S - Sale+OE | $240.31 | -30.0K | 288 | -99% | -$7.21M |
| DM | 2024-03-13 | 2024-03-11+ | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | S - Sale+OE | $247.98 | -30.0K | 9,193 | -77% | -$7.44M |
| DM | 2024-03-13 | 2024-03-11+ | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | M - OptEx | $129.49 | +30.0K | 15.1K | New | +$3.88M |
| DM | 2024-03-11 | 2024-03-07+ | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | M - OptEx | $129.49 | +30.0K | 15.1K | New | +$3.88M |
| DM | 2024-03-11 | 2024-03-07+ | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | S - Sale+OE | $241.08 | -30.0K | 6,213 | -83% | -$7.23M |
| DM | 2024-03-07 | 2024-03-05+ | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | S - Sale+OE | $234.68 | -21.3K | 130 | -99% | -$5.00M |
| DM | 2024-03-07 | 2024-03-05+ | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | M - OptEx | $129.49 | +21.3K | 6,430 | New | +$2.76M |
| DM | 2024-03-05 | 2024-03-01+ | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | COB, CEO, Dir | M - OptEx | $129.49 | +15.9K | 1,045 | New | +$2.06M |
Purchase Sale Sale after option exercise All abbreviations